SynopsisThe global Recombinant Fluorescent Proteins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Recombinant Fluorescent Proteins .....
Synopsis Highlights The global Sex Hormone Antagonist market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-1.....
SynopsisThe global Mitogen Activated Protein Kinase 9 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Mitogen Activated Protein Kinas.....
SynopsisThe global Sternum Saws market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sternum Saws in various end use industries. The expanding demands from the Or.....
SynopsisThe main component of adipoiol is recombinant human interleukin, which is a polypeptide immune enhancer.It can induce the secretion of interferon and various cytokines.Clinically, it is used for adjuvant therapy of tumor and treatment of cancerous thorax and a.....
Synopsis HemodynamicMonitoringDeviceis thedevices measuretheblood pressureinsidetheveins, heart, and arteries. Italso measures blood flow and how much oxygen is in theblood. The global Hemodynamic Monitoring Systems market size is expected to rea.....
SynopsisGlobal core EEG-EMG equipment manufacturers include Nihon Kohden and Natus etc. The Top 2 companies hold a share above 30%. North America is the largest market, with a share about 32%, followed by Europe and China with the share about 26% and 19%. .....
SynopsisThe global CAD-CAM Dental Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of CAD-CAM Dental Systems in various end use industries. The expanding.....
SynopsisThe Myocardial Infarction Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global mark.....
SynopsisRofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available b.....








